August 26, 2025

Defining optimal strategies for skull base reconstruction

Edward Kuan, MD leads a 68-expert team to define best practices for skull base reconstruction in a landmark international study.

UCI Health

June 13, 2025

FDA Approves Immune Checkpoint Inhibitor Drug for Patients With Resectable Locally Advanced Head and Neck Cancer

Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with resectable locally advanced head and neck squamous cell carcinoma whose tumors express PD-L1 [Combined Positive Score (CPS) ?1] as determined by an FDA-approved test.

Dana-Farber

August 04, 2023

Join Mount Sinai for the Seventh Annual Endoscopic Middle Ear Surgery Dissection CME Course

Course material and hands-on laboratory dissection will be appropriate for both novice and advanced endoscopic ear surgeons. For those unable to travel to New York City, this course also contains a virtual lecture component.

Mount Sinai New York

April 27, 2025

Immunotherapy Before and After Surgery Improves Outcomes in Head and Neck Cancer

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without the cancer coming back and higher rates of substantial tumor shrinkage prior to surgery, according to the first interim analysis of a randomized, open-label phase 3 clinical trial led by investigators from Dana-Farber Brigham Cancer Center and Washington University School of Medicine in St. Louis.

Dana-Farber

June 10, 2024

Dysphagia

Dr. Matthew Rohlfing, MD shares an overview of swallowing and how to evaluate dysfunctions of swallowing.

Barnes-Jewish

July 02, 2024

Join Mount Sinai for the Eighth Annual Endoscopic Middle Ear Surgery Dissection CME Course

Friday, September 13, 7:30am- Saturday, September 14, 2:00pm

Mount Sinai New York

February 09, 2023

Case Study: Otolaryngologist’s Cultural Intuition Finds Source of Patient’s Hearing Loss

Hearing loss may indicate a range of diagnoses and potential comorbidities. However, for some patients, cultural and environmental factors such as where a patient grew up may point to sources of hearing loss, including life-threatening cancers.

Keck Medicine of USC

May 16, 2023

Transforming Acoustic Neuroma Care

There’s a reason people across the country turn to Cedars-Sinai for exceptional acoustic neuroma care. Ranked #1 in California and #2 of all hospitals in the country by U.S. News & World Report, we give acoustic neuroma patients access to an unrivaled combination of top-tier talent, compassionate care and measurable results.

Cedars-Sinai Pulse

May 02, 2023

Treating Allergic Rhinitis

Ashley Tromblay presents an overview of allergic rhinitis.

Sentara